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TO THE EDITOR
The existence of an impaired skin-
barrier function in atopic eczema (AE,
also referred to as atopic dermatitis) has
been demonstrated previously, reveal-
ing the importance of the skin barrier in
the pathophysiology of AE (Jakasa et al.,
2011). Loss-of-function mutations in the
filaggrin (FLG) gene are known to be
major risk factors for developing AE
(Palmer et al., 2006). However, recent
findings report a reduced skin-barrier
function irrespective of filaggrin geno-
type, suggesting the importance of
additional factors for an impaired skin
barrier in AE (Jakasa et al., 2011).
The skin barrier is primarily provided
by the stratum corneum (SC), consisting
of enucleated cells surrounded by lipid
regions. SC lipids (primarily ceramides
(CERs), cholesterol, and free fatty acids)
form two lamellar phases: the short-
and long-periodicity phase (LPP), with
periodicities of B6 and B13 nm, re-
spectively. These periodicities were
determined by small-angle X-ray dif-
fraction (Bouwstra et al., 1991). Barrier
properties of the skin may also depend
on the lipid organization of the SC
lipids, and an altered lipid composition
or organization may cause a reduced
skin barrier in AE. Several studies have
reported on the CER composition in AE
patients (Ishikawa et al., 2010; Junger-
sted et al., 2010). In the present study,
the CER composition and lamellar lipid
organization in the SC of AE skin have
been simultaneously examined. For AE
patients, we observe drastic changes in
lipid organization, which correlate with
changes in CER composition, as com-
pared with healthy subjects.
The study was conducted in accor-
dance with the Declaration of Helsinki
Principles and approved by the Ethical
Committee of the Leiden University
Medical Center. Subjects gave written
informed consent. Six Caucasian AE
patients (23.3±5.2 years; two males)
and six Caucasian subjects without
(history of) dermatological disorders
(24.7±7.6 years; one male) were in-
cluded. The subjects did not apply any
dermatological products to their fore-
arms for at least 1 week before the
studies. To study the lipid properties
irrespective of filaggrin mutations, we
excluded subjects with any of the four
most prevalent mutations found in
European Caucasians: 2282del4, R501X,
S3247X, and R2447X, analyzed by
genotyping (Sandilands et al., 2007).
The lamellar lipid organization was
studied using 4-mm biopsies harvested
from the ventral forearm of uninvolved
skin. The local severity of uninvolved
AE skin was evaluated by local SCOR-
ing Atopic Dermatitis (Stalder and
Taieb, 1993) and was 0 for all patients.
SC was isolated by trypsin digestion
(Tanojo et al., 1997) and analyzed by
small-angle X-ray diffraction using a
microfocus beam (European Synchro-
tron Radiation Facility, Grenoble,
France), similarly as described else-
where (Bras et al., 2003). The CER
composition was examined in SC har-
vested by tape stripping uninvolved
regions from the ventral forearm (PPS
tape, Nichiban, Tokyo, Japan) close to
the region of the biopsy. Tape strip
numbers 6–9 were extracted, pooled,
and analyzed by liquid chromato-
graphy (Alliance 2695, Waters, Milford,
MA, USA) coupled to mass spectro-
metry (TSQ-Quantum, Thermo
Finnigan, San Jose, CA) (Thakoersing
et al., 2010; van Smeden et al., 2011).
The nomenclature of used CERs is
described previously (Motta et al.,
1993). Briefly, CERs contain a fatty-
acid chain (an esterified o-hydroxy
(EO), a-hydroxy (A), or non-hydroxy
(N) fatty acid) linked via an amide to a
sphingosine chain (a sphingosine (S), dihy-
drosphingosine (dS), phytosphingosine (P),
Abbreviations: AE, atopic eczema; CER, ceramide; EO, esterified o-hydroxy; LPP, long-periodicity phase;
SC, stratum corneum
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or 6-hydroxysphingosine (H)), resulting
in 12 CER subclasses.
Figure 1a shows three SC diffraction
patterns representative for healthy sub-
jects. The periodicity of the LPP was
obtained from the peak positions
(Bouwstra et al., 1991). All healthy
subjects show three LPP peak positions
(first, second, and third order) at scatter-
ing vector values (q) 0.50, 1.00 (main
peak), and 1.45 nm1, respectively,
corresponding to a periodicity of
12.6 nm. The first-order peak of the
short-periodicity phase also contributes
to the main peak, which is located at a
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Figure 1. Small angle X-ray diffraction analysis of biopsies taken from the ventral forearm. Diffraction patterns of (a) healthy subjects, (b) atopic eczema
patients, and (c) boxplots showing the variance of the main peak position in both groups. The inset in the upper right corner of a schematically represents
the lipid organization and shows the periodicity of the LPP (dE12.6 nm). and indicate patients with an altered small angle X-ray diffraction (SAXD)
profile (indicated by * and **). # Indicates phase-separated cholesterol. From the positions of the peaks (q) the repeat distance of the long-periodicity phase (LPP)
was calculated using the equation d¼n  2p/qn (n¼order of diffraction peak). The main peak is also caused by the first-order diffraction peak of the
short-periodicity phase (SPP) located at slightly higher q-values than the second order of the LPP.
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Figure 2. Liquid-chromatography mass-spectrometry analysis on human stratum corneum ceramides obtained from tape strips taken from the ventral
forearm. To permit semi-quantitative analysis, two deuterated ceramides (CER [E(18:2)O(30)S(18)] and CER [N(24)S(18)]) were used as internal standards. (a) Bar
graph of the relative ceramide abundance (in percentages) of every ceramide subclass of healthy subjects (black bars) and atopic eczema (AE) patients (gray bars)
(mean±SD, n¼ 12). An unpaired Student’s t-test showed a significant difference in NP content between healthy and AE subjects (Po0.005). (b) Boxplot
of the relative ceramide abundance (in percentages) of the ceramide (esterified o-hydroxy (EO)) subclasses, showing the individual data points (n¼ 12).
White and gray boxes represent healthy subjects and AE patients, respectively. Analysis of variance showed a significant difference in the total EO content
(EOdSþ EOSþ EOPþ EOH: Po0.05). Individual AE patients marked as and correspond to the same patients labeled in Figure 1.
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slightly higher q-value. Figure 1b shows
diffraction patterns of AE patients. The
top diffraction pattern closely resembles
those of healthy subjects and is repre-
sentative for four patients. However,
two patients (marked and ) show a
different pattern: the central curve shows
a shift in the main diffraction peak to a
q-value of 1.06 nm1 (labeled *). The
lower curve shows only a single reflec-
tion at q¼ 1.20 nm1 (labeled **).
Increased q-values of the peak positions
signify shorter periodicities of the
lamellar phases in the SC of those
patients. The boxplots (Figure 1c) show
a small variance between the six
healthy subjects, but a large variance
within the group of patients.
Figure 2a shows the CER composi-
tion analyzed by liquid-chromatogra-
phy mass spectrometry. All 12 CER
subclasses were observed, including
the newly identified CER (EO dihydro-
sphingosine) (van Smeden et al., 2011).
The observed CER profile is very similar
to that observed in previous studies
using a fully quantitative method (Masu-
kawa et al., 2009; Ishikawa et al.,
2010). AE skin showed a significant
decrease in the abundance of CER (NP)
content (Po0.005, Student’s t-test) and in
the content of long-chain CERs (i.e.
subclass (EO), Figure 2b, Po0.05, two-
way analysis of variance), which is in
accordance to recent findings (Ishikawa
et al., 2010). The highest reduction in
abundance of CER (EO) subclasses was
observed in patients showing an altered
X-ray diffraction pattern: and in parti-
cular (Figures 1 and 2). Previous studies
have shown that the LPP may be impor-
tant for the skin barrier function (de Jager
et al., 2005): isolated human CERs with a
decreased CER (EO) level showed a
strong reduction in formation of the LPP
(Bouwstra et al., 2002). This variation in
structure results in a more dominant
influence of the first-order small-angle
X-ray diffraction peak of the short-
periodicity phase on the main small-angle
X-ray diffraction peak, which explains
the shift in peak position in the diffraction
patterns of the two AE patients.
To our knowledge, our studies de-
monstrate for the first time that a
change in CER composition can be
associated with a change in the lamel-
lar lipid organization in AE patients
compared with healthy subjects. This
association may lead to a better under-
standing of the altered SC lipid barrier
in AE.
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